Heart Test Laboratories Inc. Warrant (HSCSW)
$0.05
$0.01
(24.32%)
As on 02-Sep-2026 11:15EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Heart Test Laboratories Inc. Warrant (HSCSW)
| -28.6 | 30.1 | -29.0 | -16.6 | -10.6 | -- | -- |
|
BSE Sensex*
| -10.1 | -2.5 | 2.0 | -5.0 | 5.2 | 5.7 | 10.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Heart Test Laboratories Inc. Warrant (HSCSW)
| 133.2 | -39.6 | -82.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Heart Test Laboratories Inc. Warrant (HSCSW)
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to... detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas. Read more
-
CEO, President & Chairman of the Board of Directors
Mr. Andrew Simpson
-
CEO, President & Chairman of the Board of Directors
Mr. Andrew Simpson
-
Headquarters
Southlake, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Heart Test Laboratories Inc. Warrant (HSCSW)
What is the current share price of Heart Test Laboratories Inc Warrant (HSCSW) Today?
The share price of Heart Test Laboratories Inc Warrant (HSCSW) is $0.05 (NASDAQ) as of 02-Sep-2026 11:15 EDT. Heart Test Laboratories Inc Warrant (HSCSW) has given a return of -10.55% in the last 3 years.
What is the current PB & PE ratio of Heart Test Laboratories Inc Warrant (HSCSW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
-- |
-- |
2025 |
-- |
-- |
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
What is the 52 Week High and Low of Heart Test Laboratories Inc Warrant (HSCSW)?
The 52-week high and low of Heart Test Laboratories Inc Warrant (HSCSW) are Rs 0.15 and Rs 0.03 as of 04-Sep-2026.
What is the market cap of Heart Test Laboratories Inc Warrant (HSCSW)?
Heart Test Laboratories Inc Warrant (HSCSW) has a market capitalisation of -- as on 27-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Heart Test Laboratories Inc Warrant (HSCSW)?
Before investing in Heart Test Laboratories Inc Warrant (HSCSW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.